Current TAT: 24 hours
Respiratory Pathogens Testing
Patients Choice Laboratories provides the accuracy and speed necessary for clinicians to effectively identify and address respiratory infections. Our tests use Real-Time PCR to identify specific and even polymicrobial infections. Point-of-care assays have limited ability to test for multiple disease states, which can lead to delays in proper diagnoses and lends to the progression and transmission of the infection.
Respiratory tract infections can be caused by viral or bacterial pathogens. The symptoms caused by these different pathogens are nearly indistinguishable. Therefore, rapid and accurate diagnosis of the responsible pathogen can aid healthcare providers in properly diagnosing patients, improve patient management, limit transmission, and reduce overall healthcare costs.
Between 9 and 45 million people contract the flu each year
Complications for flu can include bacterial pneumonia, ear infections, sinus infections, dehydration, and worsening of chronic medical conditions such as congestive heart failure, asthma, or diabetes.
Pneumonia leads to approximately 1.3 million emergency department visits per year and causes more than 50,000 deaths.
The flu and pneumonia combined rank in the top ten for leading causes of death in United States
Annually, more than 10,000,000 people suffer from chronic bronchitis in United States
Patients Choice Advantage
Results in under 24 hours
Extensive antibiotic resistance panel for bacterial and viral pathogens
Partnered with world class PharmD group to provide individualized Arkstone Report
Rapid PCR results on pathogen identification
Higher sensitivity than conventional culture
Identify multiple bacterial and viral infections (polymicrobial)
Easy-to-read Reporting and EHR Integration
The following pathogens are detected in our RPP+ test.
Antibiotic Resistance Markers Identified
Determine which antibiotics may be ineffective for a more accurate treatment plan.
Collection and detection window details.